Jun 28, 2026
15 MIN READ

Understanding Wegovy Side Effects: What You Need to Know

Semaglutide can cause nausea, vomiting, and constipation in the first weeks of treatment, but most side effects resolve within 4-8 weeks as your body adjusts. Understanding what to expect helps you stay committed to your weight loss goals.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 28, 2026
15 MIN READ

understanding wegovy side effects: what you need to know — PlexusDx GLP-1 education

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, which is why digestive side effects are common during the first month of treatment. Most patients experience mild to moderate symptoms that decrease significantly over time. Knowing what side effects are normal—and when to seek support—empowers you to succeed with GLP-1 therapy.

Common Semaglutide Side Effects and Timeline

The most frequently reported semaglutide side effects include nausea, vomiting, diarrhea, and constipation. These effects typically peak during the first 2-3 weeks after starting treatment or increasing your dose, then gradually improve as your digestive system adapts to the medication. Clinical trials show that 70% of patients report some nausea initially, but fewer than 10% experience severe symptoms that lead to treatment discontinuation.

Appetite suppression is actually the intended effect of semaglutide, but it can feel overwhelming at first. Many patients report difficulty finishing meals, food aversions, and reduced interest in foods they previously enjoyed. This response usually stabilizes within 4-6 weeks, allowing you to eat normally while maintaining the appetite-reducing benefits that support weight loss.

Managing Nausea and Digestive Discomfort

Eating smaller, more frequent meals reduces the burden on your stomach and can significantly decrease nausea during the adjustment period. Avoiding high-fat and greasy foods, staying hydrated, and eating slowly help your digestive system tolerate semaglutide better. Ginger tea, crackers, and bland proteins like chicken or fish are well-tolerated by most patients experiencing mild nausea.

If nausea persists beyond the first 6 weeks or becomes severe, your PlexusDx care team can adjust your dosing schedule or recommend over-the-counter remedies. Prescription anti-nausea medications are available if needed, though most patients achieve comfort through dietary modifications alone. Taking your injection at the same time each week and maintaining consistent meal timing also helps your body establish a new rhythm.

Constipation and Bowel Changes on Semaglutide

Constipation occurs because semaglutide slows gastric motility and reduces overall food intake, both of which can decrease bowel frequency. Increasing fiber intake gradually—through vegetables, whole grains, and psyllium supplements—helps normalize bowel movements without overwhelming your system. Drinking at least 8-10 glasses of water daily and light exercise like walking support digestive regularity.

Some patients experience alternating constipation and diarrhea during the first month, which typically resolves as your body stabilizes. If constipation becomes problematic, stool softeners like docusate or osmotic laxatives such as polyethylene glycol are safe options that don't interact with semaglutide. Avoid stimulant laxatives, which can cause cramping and dependence.

Serious Side Effects and When to Contact Your Provider

While rare, semaglutide can cause serious side effects including pancreatitis, severe allergic reactions, and gallbladder problems. Contact your healthcare provider immediately if you experience severe abdominal pain, persistent vomiting that prevents you from keeping food or liquids down, signs of allergic reaction (swelling of lips or throat), or yellowing of skin or eyes. These symptoms require urgent medical evaluation regardless of how unlikely they seem.

Dehydration risk increases if you experience vomiting or diarrhea, particularly in warm weather or during exercise. Watch for signs like extreme thirst, dark urine, dizziness, or fatigue. PlexusDx providers monitor your treatment closely and can address concerning symptoms quickly—contact your care team if you're unsure whether your symptoms warrant immediate attention.

Personalized Side Effect Management with Genetic Insights

PlexusDx Precision Peptide Genetic Test identifies genetic variations in GLP-1 receptor pathways and other peptide-related genes that influence how your body responds to semaglutide. Patients with certain variants in the GLP1R gene (rs6923761) may experience stronger appetite suppression or more pronounced early side effects, helping your care team anticipate and manage your unique response. Understanding your genetic profile allows for proactive dosing strategies that minimize discomfort.

The test also examines variants in genes affecting gastrointestinal function, appetite regulation, and energy metabolism across 14 pathways and 49 peptides. This precision approach means your PlexusDx provider can recommend individualized support strategies—from dietary changes to dose timing adjustments—tailored to your genetic predispositions rather than generic guidance. After your first month of treatment, adding the Precision Peptide Genetic Test ($99) optimizes your long-term outcomes and side effect tolerance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long do semaglutide side effects typically last?

Most side effects like nausea, vomiting, and constipation peak during the first 2-3 weeks and significantly improve within 4-8 weeks as your body adjusts. Some patients experience mild symptoms longer, but severe effects that persist beyond 8 weeks are uncommon and warrant discussion with your PlexusDx provider about dose adjustments or alternative strategies.

Is nausea on semaglutide a sign that it's working?

Nausea is a common side effect as your stomach adapts to the medication's effects on gastric motility, but it's not a requirement for weight loss. Many patients lose weight successfully with minimal or no nausea. Your dose effectiveness is measured by appetite reduction and weight change, not by side effect severity.

Can I prevent semaglutide side effects before they start?

Starting at a low dose and increasing gradually—a strategy called dose titration—significantly reduces side effect severity. PlexusDx Semaglutide Injection begins at $149/month and follows a carefully spaced dosing schedule designed to minimize digestive disruption. Eating smaller meals, staying hydrated, and avoiding high-fat foods before side effects occur also provides preventive benefit.

What should I do if I can't tolerate semaglutide?

If side effects are unmanageable, your PlexusDx provider can pause treatment temporarily, reduce your dose, or switch you to an alternative GLP-1 medication like Tirzepatide Injection or Oral Semaglutide. Some patients tolerate different formulations better, and PlexusDx offers multiple options to find what works best for your body.

Can genetic testing predict how I'll respond to semaglutide?

PlexusDx Precision Peptide Genetic Test examines key variants including GLP1R rs6923761 and MC4R rs17782313 that influence appetite regulation and medication response. Testing after your first month ($99 add-on) identifies whether genetic factors predict stronger side effects or appetite suppression, enabling your provider to optimize your treatment and side effect management strategy.

Is it safe to take anti-nausea medication with semaglutide?

Yes, over-the-counter options like ginger supplements and prescription anti-nausea medications like ondansetron are safe to use alongside semaglutide when recommended by your provider. Discuss any medications you're considering with your PlexusDx care team to ensure no interactions with your current treatment plan.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves